Search Results 1201-1210 of 17184 for monoclonal antibody

1. A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

   Anti-CD20 monoclonal antibodies within 7 days prior to leukapheresis 11. Venetoclax within 4 days prior to leukapheresis 12. Idelalisib or duvelisib within ...

2. A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) - Mayo Clinic

   GSK3511294 (long-acting anti-IL-5) in the past 12 months. 5. Treatment with any of the following monoclonal antibody therapies within 120 days prior to ...

3. A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

   Receipt of an investigational immunomodulator or monoclonal antibody within 180 days (or 5 half-lives, whichever is longer) prior to Screening. Receipt of ...

4. A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing - Mayo Clinic

   any indication, including but not limited to chemotherapy, small molecules, monoclonal antibodies, or radiotherapy (with bone marrow impact) within 2 weeks ...

5. A Study of the Safety and Effectiveness of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unremoveable Malignant Pleural Mesothelioma - Mayo Clinic

   ... monoclonal antibody therapy, amatuximab or any of its excipients); Pregnant and/or lactating females are excluded. A negative beta-human chorionic ...

6. A Study to Evaluate the Effectiveness, Safety and Tolerability of Efgatigimod PH20 SC in Adults with Pemphigus - Mayo Clinic

   plasmapheresis/ plasma exchange, immunoadsorption, and IVIg. 5. Use of any monoclonal antibody (including rituximab or another anti-CD20 biologic) within 6 ...

7. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

   Prior treatment with monoclonal antibodies or any radio- or toxin- immunoconjugates within 3 months of study drug administration. However rituximab treatment ...

8. Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract - Mayo Clinic

   Documented to be RSV-positive as determined by local testing (eg, polymerase chain reaction, direct fluorescence antibody ... monoclonal anti-RSV antibodies ...

9. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

   Exposure to another investigative drug (small molecules as well as monoclonal antibodies) ... The minimum interval since exposure to any other (non-antibody) ...

10. INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure - Mayo Clinic

    Patients with heart failure (HF) have lower initial antibody responses to the influenza vaccine compared with healthy individuals. Whether antibody titers wane ...